欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DK/H/1911/002
药品名称Lansale
活性成分
    • lansoprazole 30.0 mg
剂型Gastro-resistant capsule, hard
上市许可持有人splitting procedure: New splitted procedure number is IE/H/0575/001-002/DC and IT/H/0620/001-002 Actavis Group PTC ehf. Reykjavikurvegur 76-78 220 Hafnarfjordur Iceland
参考成员国 - 产品名称Denmark (DK)
Lansale
互认成员国 - 产品名称
    许可日期2011/12/19
    最近更新日期2020/04/21
    药物ATC编码
      • A02BC03 lansoprazole
    申请类型
    • TypeLevel1:Abridged
    • TypeLevel2:Initial Application
    • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
    • TypeLevel4:Chemical Substance
    • TypeLevel5:Prescription Only
    附件文件下载
    市场状态Withdrawn(注:已撤市)
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase